Molecular risk assessment is a procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person's risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.
| Molecular risk assessment | |
|---|---|
| Purpose | estimate a person risk of getting cancer |
Sources edit
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
External links edit
- Molecular risk assessment entry in the public domain NCI Dictionary of Cancer Terms
 | This oncology article is a stub. You can help Wikipedia by expanding it. |